18F-fluorodeoxyglucose positron emission tomography in small-cell lung cancer.

Positron emission tomography (PET) imaging is not used routinely in small-cell lung cancer (SCLC) but has been proven useful in non-small-cell lung cancer. The performance of (18)F-fluorodeoxyglucose (FDG)-PET in patients with SCLC was evaluated in this study. Fifteen patients with proven SCLC were evaluated (8 men and 7 women; mean age, 68 years; range, 50-81 years). Among the 15 patients with SCLC, 3 were newly diagnosed and 12 had received chemotherapy or radiation therapy before PET. Five patients underwent surgery (3 newly diagnosed and 2 after therapy) after PET scan, and 14 received chemotherapy, radiation therapy, or both. The patient who was not treated with chemotherapy or radiation therapy underwent surgery only. All patients had computed tomographic (CT) scans before PET and had clinical follow-up for at least 2 months after PET. The patients received 3.4 to 4.15 mCi of (18)F-FDG intravenously after fasting for at least 4 hours. Whole-body PET scans were acquired approximately 50 min after injection by using an ADAC Laboratories C-PET plus scanner. Among the 12 patients treated before PET, 2 were found with solitary pulmonary nodules positive on PET. Subsequent surgical resection and pathology showed 1 true positive and 1 false positive (postradiation pneumonitis). Six of these 12 patients had extrapulmonary metastases or large intense hilar or pulmonary uptake on PET, or both. Four of these 12 had no evidence of abnormal FDG uptake and were considered true negatives. The 3 patients with newly diagnosed SCLC were all true positives on PET, confirmed by surgery. One false negative on CT scan was attributed to postradiation fibrosis. These preliminary data suggest that whole-body FDG-PET can provide the basis for determining which treatment modality would be the most appropriate during the early stages of SCLC, when surgery is still an option, and it is a useful tool to assess the effect of treatment in patients with this disease. A more accurate assessment of SCLC will be possible if FDG-PET scan is combined with CT during the early evaluation of these patients.

[1]  P C Goodman,et al.  Staging non-small cell lung cancer with whole-body PET. , 1999, Radiology.

[2]  H. Hansen,et al.  Surgery in limited stage small cell lung cancer. , 1999, Cancer treatment reviews.

[3]  S. Miyoshi,et al.  Surgical results for small cell lung cancer based on the new TNM staging system. Thoracic Surgery Study Group of Osaka University, Osaka, Japan. , 2000, The Annals of thoracic surgery.

[4]  K. Fujimori,et al.  A pilot phase 2 study of surgical treatment after induction chemotherapy for resectable stage I to IIIA small cell lung cancer. , 1997, Chest.

[5]  D. Scholes,et al.  Long-term survival in small-cell carcinoma of the lung: a population experience. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  R. Makuch,et al.  Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Data on potential cures, chronic toxicities, and late relapses after a five- to eleven-year follow-up. , 1985, Annals of internal medicine.

[7]  V. Lowe,et al.  Positron emission tomography in lung cancer. , 1998, The Annals of thoracic surgery.

[8]  A. Pforte,et al.  Positron emission tomography in the staging of small-cell lung cancer : a preliminary study. , 2001, Chest.

[9]  M P Frick,et al.  Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. , 1993, Chest.

[10]  D Delbeke,et al.  Prospective investigation of positron emission tomography in lung nodules. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Lee Goldman,et al.  Cecil Textbook of Medicine , 1985 .

[12]  E. Gunel,et al.  Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  J. Lammers,et al.  Staging of lymph nodes with FDG dual-headed PET in patients with non-small-cell lung cancer. , 1999, Nuclear medicine communications.

[14]  R. Ginsberg,et al.  Surgical treatment for limited small-cell lung cancer. The University of Toronto Lung Oncology Group experience. , 1991, The Journal of thoracic and cardiovascular surgery.

[15]  N. Dewan,et al.  Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan. , 1997, Chest.

[16]  P. Wingo,et al.  Cancer statistics, 1996 , 1996, CA: a cancer journal for clinicians.